엔도톡신 검사 시장 보고서(2025년)

Endotoxin testing, also known as the bacterial endotoxins test (BET), is a laboratory-based assay designed to evaluate the levels of bacterial endotoxins in substances, with a particular focus on pharmaceuticals and medical devices. The primary goal of this testing is to ensure product safety and compliance with stringent quality standards, thereby reducing the risk of potential adverse effects on patients and users.

Endotoxin testing encompasses various methods, including LAL (limulus amebocyte lysate) tests, chromogenic tests, turbidimetric tests, gel clot tests, MAT tests, rabbit pyrogen tests, and recombinant factor C (rFC) assays. Among these, the LAL test stands out as a highly sensitive assay employed to detect bacterial endotoxins in medical and pharmaceutical products. This method leverages the clotting response of horseshoe crab blood components to identify the presence of endotoxins. The LAL test is applicable in diverse areas, such as medical devices, pharmaceuticals, packaging, and raw materials, and is utilized by various end-users, including hospitals, laboratories, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The endotoxin testing market research report is one of a series of new reports from The Business Research Company that provides endotoxin testing market statistics, including endotoxin testing industry global market size, regional shares, competitors with an endotoxin testing market share, detailed endotoxin testing market segments, market trends and opportunities and any further data you may need to thrive in the endotoxin testing industry. This endotoxin testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endotoxin testing market size has grown steadily in recent years. It will grow from $2.24 billion in 2024 to $2.31 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to increasing demand for biologics and biosimilars, growing awareness about the importance of endotoxin testing, growing prevalence of infectious diseases.

The endotoxin testing market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to expansion of the biopharmaceutical industry, increasing investment in research and development of endotoxin testing, global healthcare expansion. Major trends in the forecast period include innovative endotoxin detection tools, adoption of endotoxin testing service, demand for endotoxin testing services.

The forecast of 5.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. pharmaceutical safety by increasing costs for Limulus Amebocyte Lysate (LAL) testing reagents imported from Indonesia and Malaysia, potentially delaying drug releases and raising QC lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing incidence of healthcare-associated infections is poised to be a significant driver for the expansion of the endotoxin testing market. Healthcare-associated infections pertain to infections that individuals acquire while receiving medical treatment and were not present at the time of their admission to a healthcare facility. These infections often result from contaminated medical equipment or procedures, emphasizing the need for thorough testing to ensure patient safety. Endotoxin testing services play a vital role in preventing healthcare-associated infections by evaluating bacterial endotoxin levels in various medical equipment, particularly in injectable pharmaceutical products and implantable medical devices. For instance, as of December 2022, reports from the United Nations International Children's Emergency Fund (UNICEF) indicated that pneumonia was the infectious disease claiming the most children's lives, causing over 700,000 annual fatalities, which equates to approximately 2,000 children per day. Moreover, according to the World Health Organization's data from May 2022, approximately 24% of patients are affected by healthcare-associated sepsis each year, and the mortality rate for patients treated in intensive care units is as high as 52.3% annually. Consequently, the increasing prevalence of healthcare-associated infections is a major driving force behind the growth of the endotoxin testing market.

The increasing demand for biologics to conduct various tests is expected to drive the growth of the endotoxin testing market. Biologics, also referred to as biopharmaceuticals, are pharmaceuticals developed using living organisms, cells, or biological processes. Endotoxin testing is critical for biologics to ensure their safety, quality, and compliance with regulatory standards. For example, in May 2022, the European Pharmaceutical Review (EPR), a UK-based non-governmental organization, reported that biologics are projected to significantly surpass sales of innovative small molecules in the next five years, with an expected $120 billion increase in sales by 2027. This signifies a notable shift in the pharmaceutical market toward biologic products. As a result, the growing demand for biologics to conduct various tests is driving the expansion of the endotoxin testing market.

Key players in the endotoxin testing market are dedicated to embracing cutting-edge technological solutions to maintain their market standing. As an example, in August 2023, Lonza Group AG, a Switzerland-based pharmaceutical, biotechnology, and nutrition manufacturing company, introduced the Nebula absorbance reader, a novel absorbance microplate reader designed to streamline endotoxin and pyrogen testing. This instrument seamlessly integrates with Lonza's latest WinKQCL software to enhance data integrity compliance, expedite training, and reduce validation requirements. Users of WinKQCL software are no longer burdened with the need to learn new software to utilize this state-of-the-art reader, resulting in reduced training efforts. The Nebula Absorbance Reader is a forward-thinking and technologically advanced replacement reader that yields results akin to those frequently obtained with the ELx808, the industry-standard absorbance reader that Lonza no longer offers for sale. Furthermore, it is designed to be fully compatible with and meet the stringent requirements of Lonza's absorbance-based endotoxin assays, including the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.

In January 2022, Suez Water Technologies and Solutions, a prominent water treatment company based in the United States, completed the acquisition of Sentinel Monitoring Systems Inc. for an undisclosed sum. This strategic acquisition serves to enhance Veolia Water Technologies & Solutions' analytical instrument line while unlocking new opportunities in the microbiological monitoring market. Sentinel Monitoring Systems Inc., a US-based company, specializes in the development of online bioburden monitoring tools and instrument platforms designed for endotoxin testing.

Major companies operating in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMerieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.

North America was the largest region in the endotoxin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endotoxin testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endotoxin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endotoxin testing market consists of revenues earned by entities by providing contract testing services, ecologically sustainable testing and rapid testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endotoxin testing market also includes sales of injectable pharmaceutical products, endotoxin detection systems, limulus amebocyte lysate test reagents and polymerase chain reaction mycoplasma detection kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endotoxin Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endotoxin testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endotoxin testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endotoxin testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: LAL (Limulus Amebocyte Lysate) Test; Chromogenic Tests; Turbidimetric Tests; Gel Clot Tests; MAT Test; Rabbit Pyrogen Test; Recombinant Factor C (rFC) Assay
• 2) By Application: Medical Devices; Pharmaceuticals; Packaging; Raw Materials
• 3) By End-User: Hospitals; Laboratories; Research Institutes
• Subsegments:
• 1) By LAL (Limulus Amebocyte Lysate) Test: Gel Clot LAL Test; Kinetic LAL Test; Endpoint LAL Test
• 2) By Chromogenic Tests: Chromogenic LAL Test; Chromogenic Factor C Assay
• 3) By Turbidimetric Tests: Turbidimetric LAL Test; Turbidimetric Factor C Assay
• 4) By Gel Clot Tests: Gel Clot LAL Test
• 5) By MAT Test (Monocyte Activation Test): Direct MAT; Indirect MAT
• 6) By Rabbit Pyrogen Test: Standard Rabbit Pyrogen Test
• 7) By Recombinant Factor C (rFC) Assay: RFC Assay For Endotoxin Detection
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; bioMerieux SA.; Eurofins Scientific SE; Lonza Group Ltd.; WuXi AppTec Co. Ltd.; Bio-Rad Laboratories Inc.; Maravai LifeSciences Holdings Inc.; Cambrex Corporation; GenScript Biotech Corporation; Charles River Laboratories International Inc.; Nelson Laboratories LLC; Lifecore Biomedical Inc.; Stellar Biotechnologies Inc.; Biovision Inc.; Associates of Cape Cod Inc.; FUJIFILM Wako Pure Chemical Corporation; InvivoGen Inc.; Tebu-bio Nv.; MatTek Corporation; Microcoat Biotechnologie GmbH; Accelagen Inc.; BioAssay Systems LLC; BioThema AB; Hycult Biotech Inc.; Pacific Biolabs Inc.; Xiamen Bioendo Technology Co. Ltd.; Zhanjiang A&C Biological Ltd.; Accugen Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endotoxin Testing Market Characteristics

3. Endotoxin Testing Market Trends And Strategies

4. Endotoxin Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Endotoxin Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Endotoxin Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Endotoxin Testing Market Growth Rate Analysis
• 5.4. Global Endotoxin Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Endotoxin Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Endotoxin Testing Total Addressable Market (TAM)

6. Endotoxin Testing Market Segmentation

• 6.1. Global Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• LAL (Limulus Amebocyte Lysate) Test
• Chromogenic Tests
• Turbidimetric Tests
• Gel Clot Tests
• MAT Test
• Rabbit Pyrogen Test
• Recombinant Factor C (rFC) Assay
• 6.2. Global Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Devices
• Pharmaceuticals
• Packaging
• Raw Materials
• 6.3. Global Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Laboratories
• Research Institutes
• 6.4. Global Endotoxin Testing Market, Sub-Segmentation Of LAL (Limulus Amebocyte Lysate) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gel Clot LAL Test
• Kinetic LAL Test
• Endpoint LAL Test
• 6.5. Global Endotoxin Testing Market, Sub-Segmentation Of Chromogenic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chromogenic LAL Test
• Chromogenic Factor C Assay
• 6.6. Global Endotoxin Testing Market, Sub-Segmentation Of Turbidimetric Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Turbidimetric LAL Test
• Turbidimetric Factor C Assay
• 6.7. Global Endotoxin Testing Market, Sub-Segmentation Of Gel Clot Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gel Clot LAL Test
• 6.8. Global Endotoxin Testing Market, Sub-Segmentation Of MAT Test (Monocyte Activation Test), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct MAT
• Indirect MAT
• 6.9. Global Endotoxin Testing Market, Sub-Segmentation Of Rabbit Pyrogen Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Rabbit Pyrogen Test
• 6.10. Global Endotoxin Testing Market, Sub-Segmentation Of Recombinant Factor C (rFC) Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RFC Assay For Endotoxin Detection

7. Endotoxin Testing Market Regional And Country Analysis

• 7.1. Global Endotoxin Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Endotoxin Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endotoxin Testing Market

• 8.1. Asia-Pacific Endotoxin Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endotoxin Testing Market

• 9.1. China Endotoxin Testing Market Overview
• 9.2. China Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endotoxin Testing Market

• 10.1. India Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endotoxin Testing Market

• 11.1. Japan Endotoxin Testing Market Overview
• 11.2. Japan Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endotoxin Testing Market

• 12.1. Australia Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endotoxin Testing Market

• 13.1. Indonesia Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endotoxin Testing Market

• 14.1. South Korea Endotoxin Testing Market Overview
• 14.2. South Korea Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endotoxin Testing Market

• 15.1. Western Europe Endotoxin Testing Market Overview
• 15.2. Western Europe Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endotoxin Testing Market

• 16.1. UK Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endotoxin Testing Market

• 17.1. Germany Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endotoxin Testing Market

• 18.1. France Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endotoxin Testing Market

• 19.1. Italy Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endotoxin Testing Market

• 20.1. Spain Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endotoxin Testing Market

• 21.1. Eastern Europe Endotoxin Testing Market Overview
• 21.2. Eastern Europe Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endotoxin Testing Market

• 22.1. Russia Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endotoxin Testing Market

• 23.1. North America Endotoxin Testing Market Overview
• 23.2. North America Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endotoxin Testing Market

• 24.1. USA Endotoxin Testing Market Overview
• 24.2. USA Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endotoxin Testing Market

• 25.1. Canada Endotoxin Testing Market Overview
• 25.2. Canada Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endotoxin Testing Market

• 26.1. South America Endotoxin Testing Market Overview
• 26.2. South America Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endotoxin Testing Market

• 27.1. Brazil Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endotoxin Testing Market

• 28.1. Middle East Endotoxin Testing Market Overview
• 28.2. Middle East Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endotoxin Testing Market

• 29.1. Africa Endotoxin Testing Market Overview
• 29.2. Africa Endotoxin Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Endotoxin Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Endotoxin Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endotoxin Testing Market Competitive Landscape And Company Profiles

• 30.1. Endotoxin Testing Market Competitive Landscape
• 30.2. Endotoxin Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. bioMerieux SA. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Endotoxin Testing Market Other Major And Innovative Companies

• 31.1. WuXi AppTec Co. Ltd.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Maravai LifeSciences Holdings Inc.
• 31.4. Cambrex Corporation
• 31.5. GenScript Biotech Corporation
• 31.6. Charles River Laboratories International Inc.
• 31.7. Nelson Laboratories LLC
• 31.8. Lifecore Biomedical Inc.
• 31.9. Stellar Biotechnologies Inc.
• 31.10. Biovision Inc.
• 31.11. Associates of Cape Cod Inc.
• 31.12. FUJIFILM Wako Pure Chemical Corporation
• 31.13. InvivoGen Inc.
• 31.14. Tebu-bio Nv.
• 31.15. MatTek Corporation

32. Global Endotoxin Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endotoxin Testing Market

34. Recent Developments In The Endotoxin Testing Market

35. Endotoxin Testing Market High Potential Countries, Segments and Strategies

• 35.1 Endotoxin Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Endotoxin Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Endotoxin Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer